MIAMI, May 5, 2025 /PRNewswire/ -- Immorta Bio Inc, a scientific longevity company ... "Having been chosen to present our work on using the immune system to fight cancer and aging in such an ...

The A-Alpha Bio team. The Seattle startup generates protein interaction data and partners with drug ... A-Alpha Bio is among a growing flock of startups using AI as a tool to help scientists ...

CAMBRIDGE, Mass., Sept. 05, 2024 -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced new clinical data from its ongoing Phase 1/2 VBP101 study of ...

Charles River has a market capitalization of $8.89 billion. The company’s earnings yield of 6.07% compares favorably with the industry’s 3.59%. In the trailing four quarters, it delivered an ...

Chronic pain conditions, long-lasting medical conditions characterized by persistent pain in specific areas of the body, are ...

Nevertheless, I'm "sticking my neck out" and suggesting the stock merits a "Buy" recommendation, ahead of Chronic rhinosinusitis data due before the end of this year. Upstream Bio is a clinical ...

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on targeted cell therapies for autoimmune diseases, announced that updated clinical data on its investigational therapy ...